Organization WH. World report on ageing and health: World Health Organization; 2015.

Aïdoud A, Gana W, Poitau F, Debacq C, Leroy V, Nkodo JA, et al. High Prevalence of Geriatric Conditions Among Older Adults With Cardiovascular Disease. J Am Heart Assoc. 2023;12(2):e026850.

Article  PubMed  PubMed Central  Google Scholar 

Sheet SF. Older Americans & Cardiovascular Diseases. Dallas: American Stroke Association; 2013.

Google Scholar 

Xie J, Wu EQ, Zheng Z-J, Croft JB, Greenlund KJ, Mensah GA, et al. Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States. Stroke. 2006;37(10):2567–72.

Article  PubMed  Google Scholar 

Nanna MG, Abdullah A, Mortensen MB, Navar AM. Primary prevention statin therapy in older adults. Curr Opin Cardiol. 2023;38(1):11–20.

Article  PubMed  Google Scholar 

Mortensen MB, Falk E. Primary Prevention With Statins in the Elderly. J Am Coll Cardiol. 2018;71(1):85–94.

Article  PubMed  Google Scholar 

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. The Lancet. 2020;396(10263):1637–43.

Article  CAS  Google Scholar 

Nanna MG, Nelson AJ, Haynes K, Shambhu S, Eapen Z, Cziraky MJ, et al. Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease. J Am Geriatr Soc. 2023;71(4):1243–9.

Article  PubMed  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and european atherosclerosis society (EAS). Eur Heart J. 2019;41(1):111–88.

Article  Google Scholar 

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the american college of cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082–143.

PubMed  Google Scholar 

Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States From 1999–2012. JAMA. 2015;314(17):1818–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015;162(8):533–41.

Article  PubMed  PubMed Central  Google Scholar 

Rhee TG, Kumar M, Ross JS, Coll PP. Age-related trajectories of cardiovascular risk and use of aspirin and statin among U.S. adults aged 50 or older, 2011–2018. J Am Geriatr Soc. 2021;69(5):1272–82.

Article  PubMed  PubMed Central  Google Scholar 

Sarraju A, Spencer-Bonilla G, Chung S, Gomez S, Li J, Heidenreich P, et al. Statin use in older adults for primary cardiovascular disease prevention across a spectrum of cardiovascular risk. J Gen Intern Med. 2022;37(11):2642–9.

Article  PubMed  Google Scholar 

Spencer-Bonilla G, Chung S, Sarraju A, Heidenreich P, Palaniappan L, Rodriguez F. Statin use in older adults with stable atherosclerotic cardiovascular disease. J Am Geriatr Soc. 2021;69(4):979–85.

Article  PubMed  PubMed Central  Google Scholar 

Cournot M, Cambou J-P, Quentzel S, Danchin N. Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys. Int J Cardiol. 2006;111(1):12–8.

Article  PubMed  Google Scholar 

Sittiwet C, Simonen P, Gylling H, Strandberg TE. Mortality and cholesterol metabolism in subjects aged 75 years and older: the helsinki businessmen study. J Am Geriatr Soc. 2020;68(2):281–7.

Article  PubMed  Google Scholar 

Rong S, Li B, Chen L, Sun Y, Du Y, Liu B, et al. Association of Low‐Density Lipoprotein Cholesterol Levels with More than 20‐Year Risk of Cardiovascular and All‐Cause Mortality in the General Population. J Am Heart Assoc. 2022;11(15):e023690.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Z, Tonkin AM, Curtis AJ, Murray A, Zhu C, Reid CM, et al. Low-density-lipoprotein cholesterol and mortality outcomes among healthy older adults: a post hoc analysis of ASPREE Trial. J Gerontol A Biol Sci Med Sci. 2024;79(4):glad268. https://doi.org/10.1093/gerona/glad268.

Newson RS, Felix JF, Heeringa J, Hofman A, Witteman JC, Tiemeier H. Association between serum cholesterol and noncardiovascular mortality in older age. J Am Geriatr Soc. 2011;59(10):1779–85.

Article  PubMed  Google Scholar 

Ravnskov U, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 2016;6(6):e010401.

Article  PubMed  PubMed Central  Google Scholar 

Nanna MG, Navar AM, Wojdyla D, Peterson ED. The association between low-density lipoprotein cholesterol and incident atherosclerotic cardiovascular disease in older adults: results from the national institutes of health pooled cohorts. J Am Geriatr Soc. 2019;67(12):2560–7.

Article  PubMed  PubMed Central  Google Scholar 

Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. The Lancet. 2020;396(10263):1644–52.

Article  CAS  Google Scholar 

Strandberg TE. Role of statin therapy in primary prevention of cardiovascular disease in elderly patients. Curr Atheroscler Rep. 2019;21(8):28.

Article  PubMed  PubMed Central  Google Scholar 

Damluji AA, Nanna MG, Rymer J, Kochar A, Lowenstern A, Baron SJ, et al. Chronological vs biological age in interventional cardiology: a comprehensive approach to care for older adults: jacc family series. JACC Cardiovasc Interv. 2024;17(8):961–78.

Article  PubMed  Google Scholar 

Orkaby AR, Nussbaum L, Ho Y-L, Gagnon D, Quach L, Ward R, et al. The burden of frailty among U.S. veterans and its association with mortality, 2002–2012. J Gerontol: Series A. 2018;74(8):1257–64.

Article  Google Scholar 

Yourman LC, Cenzer IS, Boscardin WJ, Nguyen BT, Smith AK, Schonberg MA, et al. Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis. JAMA Intern Med. 2021;181(2):179–85.

Article  CAS  PubMed  Google Scholar 

Lee S, Smith A, Widera E, Yourman L, Schonberg M, Ahalt C. Eprognosis. 2011. https://eprognosis.ucsf.edu/calculators.php. Accessed 26 June 2024.

Parsons RE, Liu X, Collister JA, et al. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK BiobankHeart. 2023;109:1690–7.

Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093–103.

Article  PubMed  Google Scholar 

Hageman SHJ, Petitjaen C, Pennells L, Kaptoge S, Pajouheshnia R, Tillmann T, et al. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. Eur J Prev Cardiol. 2023;30(15):1705–14.

Article  PubMed  PubMed Central  Google Scholar 

Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, et al. Short-term global cardiovascular disease risk prediction in older adults. J Am Coll Cardiol. 2018;71(22):2527–36.

Article  PubMed  PubMed Central  Google Scholar 

Neumann JT, Twerenbold R, Weimann J, Ballantyne CM, Benjamin EJ, Costanzo S, et al. Prognostic value of cardiovascular biomarkers in the population. JAMA. 2024;331(22):1898–909. https://doi.org/10.1001/jama.2024.5596.

Gaziano TA, Gaziano JM. Can cardiovascular risk assessment be improved in the 21st century? JAMA. 2024;331(22):1891–3. https://doi.org/10.1001/jama.2024.7644.

He D, Wang Z, Li J, Yu K, He Y, He X, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058–68. https://doi.org/10.1093/eurheartj/ehad885.

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e563–95.

PubMed  PubMed Central  Google Scholar 

Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Covington AM, DePalma SM, et al. 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk. J Am Coll Cardiol. 2022;80(14):1366–418.

Article  PubMed  Google Scholar 

Force UPST. Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement. JAMA. 2022;328(8):746–53.

Article